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Determinants of the serum concentrations of low molecular weight
proteins in patients on maintenance hemodialysis. Factors influencing the
serum concentrations of low molecular weight proteins (LMWP) during
long-term hemodialysis were studied in 112 patients undergoing dialysis
for an average of 61.1 months (range 1 to 243). These patients were
treated with AN69, cellulose acetate, cuprophan or polysulfone mem-
branes. The following proteins were measured in serum before and after
a four hour dialysis session: cystatin C (CYST C), /32-microglobulin
(j32m), Clara cell protein (CC 16) and retinol-binding protein (RBP). Pre-
dialysis levels of the four proteins were markedly elevated. In simple
regression analysis, pre-dialysis serum concentrations of j32m and CCI6
weakly correlated with the duration of dialysis treatment, but these
relations completely disappeared when a stepwise regression analysis
was performed using as predictors age, sex, residual diuresis, body
weight loss (BWL), duration of hemodialysis and the type or ultrafil-
tration coefficient (UFC) of the membranes. The only significant
determinants which emerged from this analysis were the residual
diuresis and age which negatively correlated with CYST C, /3m and
CCI6 (residual diuresis only), and sex which influenced CYST C.
During the dialysis session, the microproteins underwent changes that
were related to their molecular radius, the membrane UFC and the
BWL. After adjustment for the latter, high flux membranes (UFC  15
mi/h m mm Hg) allowed up to 50% of CYST C and 25% of 2m to
be removed. No significant elimination of CC16 and RBP was evident.
On the basis of these results, we estimated the effective pore radius of
high flux membranes between 1.5 and 1.7 nm and that of low flux
membranes as below 1.5 nm. In conclusion, we demonstrated a marked
elevation of the pre-dialysis serum levels of four LMWP. These levels
are determined, before dialysis, by residual diuresis, age and sex, and
during the dialysis sessions, by the size of the protein, the BWL and the
UFC of the membrane. The latter had no significant impact on the
pre-dialysis serum levels of LMWP.
Low molecular weight proteins (LMWP) are readily elimi-
nated from plasma by glomerular filtration followed by reab-
sorption and catabolism in proximal tubule cells. Their plasma
level thus rises as renal function fails. These LMWP include a
great variety of proteins with different biological functions.
Most studies carried out in patients with chronic renal failure
have focused on p2-microglobulin (/32m, molecular wt 11.8 kDa)
identified as a major amyloidogenic component in long-term
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hemodialysis patients [1—3]. Other microproteins such as reti-
nol-binding protein (RBP, molecular wt 21.2 kDa) [4, 5], cysta-
tin C (CYST C, molecular wt 13.3 kDa) [6], a1-microglobulin
(molecular wt 33 kDa) [7] accumulate in the serum of uremic
patients and might also contribute to some clinical disturbances
in these patients.
The determinants of the plasma levels of LMWP in hemodi-
alysis patients are not yet clearly identified. Studies conducted
to date suggest that the residual renal function and the perme-
ability of dialysis membrane are the main factors involved in the
elimination of J32m. The contribution of other factors such as
age, duration of hemodialysis treatment, extrarenal catabolism,
biocompatibilty of dialysis materials and the formation of
amyloid deposits is still debated [8—16]. Whether the influence
of these factors extends to other microproteins remains largely
unknown. We have attempted to answer these questions by
studying the behavior in serum of patients on maintenance
dialysis of four LMWP: (1) cystatin C, a cystein-proteinase
inhibitor secreted by all nucleated cells; (2) J32m which is a
subunit of class I HLA antigens; (3) protein 1 or Clara cell
protein (CCI6, molecular wt 15.8 kDa), an a-microprotein
secreted at the surface of respiratory airways where it seems to
play an immunosuppressive role [17—21]; and (4) RBP, the
carrier protein of vitamin A in plasma. The results show that
pre-dialysis serum levels of these four microproteins are ele-
vated in hemodialyzed patients. These levels are independent of
the duration of hemodialysis treatment or the type of membrane
used but are determined only by patient-related factors (age,
sex and residual diuresis).
Methods
Patients
One hundred and twelve patients (59 males and 53 females)
with a mean age of 60.6 13.0 (males) and 59.5 14.4 (females)
years on stable maintenance hemodialysis for an average of6l.l
months (range 1 to 243) were recruited from two dialysis units.
The underlying causes of renal failure were chronic interstitial
nephritis (N 35), chronic glomerulonephritis (N = 21),
polycystic kidney disease (N = 17), diabetes mellitus (N = 8),
nephroangiosclerosis (N = 6), vasculitis (N = 6) and others (N
= 19). Fifty-seven patients were anuric, 22 had a residual
diuresis less than 500 ml/24 hr and 33 had a residual diuresis
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Table 1. Characteristics of dialyzers
UFC
Dialyzer Manufacturer Membrane
Surface
area ,n2
mi/hr•
mm Hg
H1210 Hospal AN69 1 20
H 1207 Hospal AN69 0.7 18
S3000 Hospal AN69 1.2 36
GA 4H Gambro Cuprophan 1.0 6.4
GFS Plus 12 Gambro Cuprophan 1.3 6.8
GFS Plus 16 Gambro Cuprophan 1.7 8.4
GA 6F 120H Gambro Cuprophan 1,3 3.8
DUO FLUX CD Medical Cellulose acetate 1.5 15
CA 130 Baxter Cellulose acetate 1.3 6.1
CA 210 Baxter Cellulose acetate 2.1 10
CORDIS 4000 Cordis Cellulose acetate 1.4 4.5
RAPIDO BL643 Belco Polysulfone 1.4 12.5
F 40 Fresenius Polysulfone 0.7 20
F 50 Fresenius Polysulfone 1.1 30
Abbreviation is UFC, ultraffitration coefficient. Values are provided
by the manufacturer.
higher than 500 m1124 hr. None of these patients at the time of
the study had evidence of nonrenal diseases likely to interfere
with the microproteins under study, such as chronic liver or
lung disease, malignancy or inflammatory disorders.
Dialyzer membranes
Four types of membranes were studied: AN69 (N = 72),
cellulose acetate (N = 9), cuprophan (N = 22) and polysulfone(N = 9). The ultrafiltration coefficient (UFC), which can be
regarded as an estimate of the permeability of the membrane,
ranged from 3.2 to 30 mllhr m2 mm Hg (Table 1). All patients
had been dialyzed with the same type of dialysis membrane
from the onset of dialysis treatment or at least since twelve
months, except seven patients who switched from low (cu-
prophan or cellulose acetate) to high flux (AN69, N = 6 or
polysulfone, N = 1) membrane at least one month prior to the
study (3 at 1 month and 4 between months 6 and 12). Each
patient underwent three dialysis sessions of four hours duration
per week. Reused dialyzers were sterilized with sodium hypo-
chlorite [22]. The blood flow was 250 to 350 mI/mm, and the
mean body weight loss (BWL) during a dialysis session was
1.95 0.98 kg.
Analytical methods
Blood samples were taken immediately before and after the
dialysis session. Residual diuresis was assessed on a 24-hour
urine sample obtained the day before dialysis. Creatinine in
serum and urine was measured by the Jaffé's technique. The
serum or urinary concentrations of the four proteins studied
(Table 2 lists their characteristics) were determined by a sensi-
tive immunoassay relying on the agglutination of latex particles
(latex immunoassay) [23, 24]. The effective hydrodynamic or
molecular radius (Mr) of the proteins was estimated by frac-
tionating pooled sera from 10 hemodialysis patients on a
Sephacryl S-200 column by fast protein liquid chromatography
(Pharmacia-LKB Biotechnology, Uppsala, Sweden). The con-
centrations of the proteins in the eluted fractions were deter-
mined by latex immunoassay. As shown in Figure 1, CC16,
CYST C and fi2m eluted as a single component with a molecular
size corresponding to the free protein. RBP, however, eluted in
two distinct peaks: a major peak containing about 80% of the
protein and corresponding to the free unbound protein, and a
smaller peak coeluting with albumin and composed of the
transthyretin-bound RBP.
Statistical analysis
Results were expressed as the arithmetic mean SD (SEM in
figures). Statistical tests were done by using the Statview SE
software (Abacus Concepts, 1988). The determinants of the
serum concentrations of the proteins before dialysis were
traced by stepwise regression analysis using as the dependent
variable the logarithm of the serum concentration of the pro-
tein, and as independent variables age, sex, residual diuresis,
BWL, duration of hemodialysis treatment, UFC or type of
dialysis membrane. The determinants of the variations of the
protein concentration in serum during the dialysis sessions were
identified by using as the dependent variable the logarithm of
the protein serum concentration ratio after/before dialysis, and
as predictors the BWL, the UFC or the type of dialysis
membrane, and the number of utilizations of the dialyzers. Sex,
UFC and residual diuresis were introduced in the model cate-
gorized as follows: female 0, male 1; UFC < 15,  15—20, > 20
mlJhr m2 mm Hg and residual diuresis 50, > 50—250, >
250—500, > 500—750, > 750 ml/24 hr. Comparisons between the
groups were performed by one-way analysis of variance fol-
lowed by the Scheffd's multiple comparison test with P < 0.05
considered as statistically significant.
Results
Determinants of pre-dialysis serum levels
The pre- and post-dialysis serum concentrations of the four
microproteins were markedly increased compared to the nor-
mal values (Table 2). In simple regression analysis, the concen-
trations of p2m and CC16 were positively correlated with the
duration of hemodialysis treatment (Fig. 2), but these relations
completely disappeared when a stepwise regression analysis
was performed using as predictors age, sex, residual diuresis,
BWL, duration of hemodialysis and the type or UFC of the
membranes (Fig. 2, Table 3). The stepwise regression analysis
showed indeed that the pre-dialysis serum concentrations of
CYST C, 2m and CC16 were inversely related to the residual
diuresis, the best correlated protein being f32m, followed by
CC16 and CYST C. It can be estimated that for each fraction of
250 m1124 hr of preserved residual diuresis, the pre-dialysis
serum levels of j32m and CC16 decrease on an average by 15%
and that of CYST C by 3%. The pre-dialysis serum levels of
/32m and CYST C also declined with advancing age, on the
average by 7 and 9% per decade, respectively. A significant
influence of sex was apparent for serum CYST C whose values
were higher in men than in women. It is interesting to note that,
after adjustment for other contributors, none of the proteins
studied was significantly associated with the duration of hemo-
dialysis treatment, as illustrated in Figure 2, or the type of
dialysis membrane, even when anuric patients are considered
separately (results not shown). No determinant of RBP in
serum emerged from the stepwise regression analysis.
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Table 2. Characteristics of the four microproteins studied and their concentrations in serum of patients before and after dialysis
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Characteristics
Cystain C
(CYST C)
fl2-microglobulin
(/32m)
Clara cell protein
(CC16)
Retinol binding
protein (RBP)
Origin Nucleated cells Nucleated cells Respiratory tract Liver
Function Cystein proteinase
inhibitor
HLA antigen
class I
Immunosuppressive? Transport of
vitamin A
Molecular weight kDa 13.3 11.8 15.8 21.2
Molecular radius nm 1.51 1.6 1.9 1.75
Isoelectric point p1 9.30 5.4—5.7 4.7 4.4—4.8
Normal range in serum mg/liter 0.6—1.6 1—2 0.05—0.1 50—80
Pre-dialysis values mg/litera
Post-dialysis values mg/litera
11,8 3.0
8.3 44b
38.9 13.4
37.0 151b
2.9 1.7
3•3 2.0k
166 68
192 78b
a Data are mean SD.
b P < 0.02, compared to pre-dialysis values
C0
C
a)0C
8
C
a)
20
Determinants of post-dialysis serum levels
Proteins examined separately. During the dialysis session,
the serum concentrations of the four microproteins underwent
changes that could be related to the UFC and the BWL (Table
4). The dialyzer's reuse and the type of dialysis membrane did
not emerge as significant contributors of their serum concentra-
tion changes during dialysis. As expected, the elimination of the
proteins during dialysis increased with the UFC and apparently
decreased with the BWL, the latter being an index of the
hemoconcentration.
Figure 3 shows the changes of protein concentrations in
serum during dialysis by stratifying the dialyzers according to
the UFC. This figure also compares two modes of correction for
hemoconcentration, one based on the partial regression coeffi-
cient derived from the stepwise regression analysis (Table 4)
and the other using the formula proposed for f32m by Bergstrom
and Wehie [25]. The post-dialysis serum levels of CYST C and
2m were significantly decreased at UFC  15 mlIhr m2 mm
Hg. Below this threshold the values were significantly increased
as a result of hemoconcentration. Post-dialysis serum levels of
CC16 and RBP were significantly increased for all UFC cate-
gories. Adjustment for BWL abolished almost all post-dialysis
elevations, and accentuated the decreases observed with CYST
C and /32m which reached 50 and 25%, respectively at UFC 
15 mI/hr m2 mm Hg. It is of interest to note that the adjustment
for hemoconcentration was almost the same whether it was
based on the partial regression coefficient or on the formula of
Bergstrom and Wehle [25] (Fig. 3).
All proteins combined. When a stepwise regression analysis
was performed by combining data obtained with all proteins and
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Fig. 1. Distribution of Clara cell protein (s),
cystatin C (0), 132-microglobulin (•) and
retinol-binding protein (U) in the fractions
obtained by chromatographing a pooled
specimen of serum from 10 hemodialyzed
patients on Sephac,yl S-200. Arrows indicate
Tube number markers of relative molecular mass.
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Fig. 2. Pre-dialysis serum concentrations of
cystatin C (CYST C), 2-microglobulin (2m),
Clara cell protein (CCI6) and retinol-binding
protein (RBP) as a function of duration of
hemodialysis treatment. Values are shown
unadjusted (0) or adjusted (•) for residual
diuresis (CYST C, /32m, CC16), age (CYST C,
p2m) and sex (CYST C) on the basis of the
partial regression coefficients. Data are mean
SE.
introducing the Mr as independent variable, the latter emerged
as the major contributor of their serum concentration changes
during dialysis (partial r2: 0.29, P = 0.0001), followed by the
UFC (partial r2 0.11, P = 0.0001) and the BWL (partial r2 =
0.03, P = 0.03).
Figure 4 illustrates the influence of the UFC and the Mr on
the BWL-adjusted changes of protein concentration in serum
during the hemodialysis session. In both membrane categories
with UFC values higher than 15 mt/hr m2 mm Hg, protein
removal clearly depended on the Mr. This figure also shows the
changes of serum creatinine concentration for the three UFC
categories. It appears that the high flux membranes (UFC> 15
mI/hr m2 mm Hg) allowed an unrestricted passage of CYST
C almost identical to that of creatinine. On the basis of these
data, the effective pore radius could be estimated between 1.5
and 1.7 nm for high flux membranes and below 1.5 nm for low
flux membranes.
Discussion
It is well established that the kidney plays a major role in the
catabolism of small proteins [26, 271 and that renal failure
results in a drastic elevation of their concentration in plasma
[4—7, 28—30]. The fate of these proteins during long-term hemo-
dialysis, in particular their time course as a function of treat-
ment duration, is still unclear. We studied four microproteins
with distinct functions and molecular features in patients un-
dergoing chronic hemodialysis on different types of mem-
branes. With a molecular weight ranging from 11.8 kDa (f32m) to
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Table 3. Determinants of the pre-dialysis serum levels of cystatin C
(CYST C), J32-microglobulin (/32m), Clara cell protein (CCI6) and
retinol-binding protein (RBP) in patients on maintenance
hemodialysis
Dependent
variable Independent variables Partial r2
Partial regression
coefficient
Log CYST C Age
Sex
Residual diuresis
Membrane
Body weight loss
Ultrafiltration coefficient
Hemodialysis duration
019b
O.05a
O.07a
0.0006
0.00013
0.0014
0.0005
—0.0025
0.043
—0.019
0.008
—0.002
—0.0006
—0.00005
Log f32m Age
Sex
Residual diuresis
Membrane
Body weight loss
Ultrafiltration coefficient
Hemodialysis duration
013b
0.0043
036b
0.0004
0.0025
0.00001
0.00001
—0.004
0.012
—0.06
0.0021
0.0078
0.00003
0.00001
Log CCI6 Age
Sex
Residual diuresis
Membrane
Body weight loss
Ultrafiltration coefficient
Hemodialysis duration
0.033
0.035
13"
0.005
0,001
0.04
0.012
—0.004
0.084
—0.055
0.08
—0.004
—0.009
0.0005
Log RBP Age
Sex
Residual diuresis
Membrane
Body weight loss
Ultrafiltration coefficient
Hemodialysis duration
0.024
0.0001
0.01
0.0001
0.043
0.0034
0.00001
—0.002
—0.015
—0.013
0.009
0.035
—0.002
—0.00001
a p < ,o5, bp < 0.001; otherwise statistically not significant.
21 kDa (RBP) and apI from 4.4 to 9.3, the four proteins studied
can be considered as representative of the low molecular weight
protein (LMWP) class. In addition, two of these proteins (CC 16
and CYST C) appear to have biological activities [20, 21, 31, 32]
which might contribute to some immune dysregulation or other
disturbances in hemodialysis patients.
Compared to normal values, the pre-dialysis serum levels of
RBP, CYST C, f32m and CC16 were multiplied on the average
by factors of 3, 20, 26 and 39, respectively. For the three last
proteins, these relative increases correspond well to the eleva-
tion of the free intact protein which is the only form detected by
our immunoassay. For RBP, by contrast, we could not specif-
ically measure the free form of the protein and the values
reported here correspond to the sum of the free plus the
transthyretin-bound protein. However, since 80% of RBP in the
serum of these patients occur as a free form (Fig. 1) and the
concentration of free RBP in normal serum averages 6 mg/liter
[5], it can be estimated that the concentration of free RBP is
multiplied by a factor of about 20 which is comparable to that
observed for the three other proteins. The elevation of RBP [4,
5], CYST C [6] and f32m [28—30] in the serum of patients on
long-term hemodialysis has already been reported in previous
studies. The present study is the first to demonstrate a pro-
nounced increase of CC16 in the serum of these patients. In
view of the immunosuppressive and anti-inflammatory proper-
ties of this protei [17, 20—21], its role in the physiopathology of
uremic syndrome certainly deserves further study.
The determinants of the pre-dialysis serum levels of these
Table 4. Factors influencing the changes of low molecular weight
serum proteins during a dialysis session
Dependent variable
Independent
variables Partial r2
Partial regression
coefficient
Log CYST C UFC
BWL
Membrane
Dialyzer reuse
0.45"
0.14C
0.01
0.003
—0.20
0.031
0.06
—0.01
Log 132m UFC
BWL
Membrane
0.34"
0.l2'
0.008
-0.09
0.024
0.001
Log CCl6"
Dialyzer reuse
UFC
BWL
Membrane
Dialyzer reuse
0.007
O.08C
0.13"
0.03
0.002
—0.0005
—0.04
0.031
—0.0006
0.003
Log RBPa/I UFC
BWL
Membrane
Dialyzer reuse
0.06C
0.07C
0.02
0.02
—0.026
0.021
—0.003
—0.0045
Abbreviations are: UFC, ultrafiltration coefficient (mlIhrm2mm Hg);
BWL, body weight loss.
a and b post- and pre-dialysis value, respectively C P < 0.05, dp
0.001; otherwise statistically not significant.
proteins during long-term hemodialysis have been examined by
stepwise regression analysis using as possible predictors age,
sex, residual diuresis, BWL, duration of hemodialysis treat-
ment and the type or UFC of the dialysis membrane. Only the
three first factors emerged as significant determinants for at
least one of the measured proteins. The residual diuresis, which
is used here as a surrogate of the residual renal function [33], is
negatively correlated to the pre-dialysis values of CYST C, /32m
and CC 16. These results are in agreement with those obtained
by Brown et al [8] for /32m and a,-microglobulin. The contribu-
tion of residual diuresis to the elimination of these proteins is,
however, variable: it is more important for 2m to be followed
by CC16 and CYST C and it exerts no influence on RBP. The
reason for such a variation is unclear but one might conceive
that the contribution of residual diuresis becomes significant
only for those proteins which have limited possibilities of
extra-renal elimination and therefore can reach sufficiently high
concentrations in plasma. The fact that proteins significantly
influenced by residual diuresis are precisely those with the
highest relative increase in serum (f32m and CC16) is consistent
with this hypothesis.
Age appears as the second determinant of the pre-dialysis
values of CYST C and $2m which decrease with advancing age.
This observation is of special interest because age is considered
as a risk factor in the development of /m amyloid deposits in
dialyzed patients [11, 15]. The decreased levels of f2m in aged
patients could reflect an enhanced removal of this protein from
plasma as a result of its deposition in synovial tissues. This
explanation might also apply to CYST C which could be present
in synovial tissues in view of its fibrillar structure and ability to
form amyloid deposits in the central nervous system [34—36].
Alternatively the synthesis of these LMWP might decrease with
age but to date no evidence supports this hypothesis. Whatever
their underlying mechanisms, the opposite effects of age on the
serum levels of f32m and on the propensity of hemodialyzed
patients to develop amyloid deposits reinforce the hypothesis
[12] that the elevation of /32m in plasma is not the only factor
C0
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determining the development of f32m amyloidosis in long-term
hemodialyzed patients.
It is quite remarkable that neither the duration of hemodial-
ysis therapy, nor the UFC or the type of dialysis membrane
influenced the pre-dialysis values of LMWP and this even when
only anuric patients are considered. These observations are at
variance with those of Charra, Calemard and Laurent [13] who
observed a negative correlation between plasma /32m and
duration of hemodialysis treatment. This discrepancy might
arise from the fact that Charra et a! [13] have not taken into
account the influence of age. Our findings also stand in contrast
with several reports claiming that patients treated with syn-
thetic membranes have lower pre-dialysis levels of 2m than
those treated with cuprophan membranes [37, 38]. Again, these
studies failed to take into account the effect of age and residual
diuresis, factors whose importance is well highlighted by our
Fig. 3. Pre-, post-dialysis and body weight
loss adjusted serum values of cystatin C
(CYST C), f32-microglobulin (2m), Clara cell
protein (CCJ6) and retinol-binding protein
(RBP) as a function of the ultrafiltration
coefficient (UFC). Symbols are: (t1) pre-
dialysis; (Q) crude values post-dialysis; ()
post-dialysis adjusted for weight loss; ()
post-dialysis values corrected according to
[251. Data are mean SE. * Significantly
different from pre-dialysis values.
analysis. Whatever the reality of this difference, it remains
evident that the steady state levels of LMWP in the serum of
patients on maintenance dialysis are markedly elevated and on
average the same regardless the clearing capability of the
dialysis membranes.
In contrast to determinants of the pre-dialysis levels of
LMWP in patients on chronic hemodialysis, those governing
their changes during the dialysis sessions are much more
straightforward. For each LMWP examined the UFC and BWL
emerge as significant determinants whereas the type, the sur-
face area and the reuse of dialysis membrane exert no influence.
For the latter, the explanation probably lies in the use of sodium
hypochlorite which efficiently eliminates proteins adsorbed
onto the dialyzer [39]. The use of a less effective cleaning agent
might have led to a different conclusion. BWL results either in
an increase of the serum levels of LMWP (such as low flux
*
* * *
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that of low flux membranes appears smaller than 1.5 nm. It is
5 important to stress that these molecular radii are only apparent0 for they do not take into account the possible electrostatic
interactions between microproteins and albumin or other
plasma proteins adsorbed onto the dialyzer membranes. These
proteins which are mostly negatively charged generate an
electrical field which can hinder or facilitate the passage of
rnicroproteins depending on their charge. It is thus possible that
the facilitated passage of CYST C (strongly cationic) compared
to f32m (weakly anionic) does not result only from the difference
in molecular size between both proteins but also from the
difference in molecular charge. The close correlation between
the Mr and the p1 (r = 0.90, P < 0.0001) of the studied proteins
did not allow us to study the influence of the p1 in the stepwise
regression analysis.
The fact that pre-dialysis serum levels of LMWP show no
1.80 1.90 2.00 correlation with the duration of hemodialysis treatment clearly
points at factors other than residual diuresis and the dialysis
Molecular radius, nm clearance in the disposal of these microproteins in long-term
membranes) or an attenuation of their post-dialysis fall (high
flux membranes). It is noteworthy that virtually identical ad-
justments for BWL are calculated for the four microproteins on
the basis either of the partial regression coefficient or of the
formula proposed by Bergstrom and Wehle [25]. The validity of
the assumptions underlying the latter formula is thus corrobo-
rated. The fact that all proteins studied show a post-dialysis
elevation of a comparable magnitude (between 10 and 25%) in
low flux membranes (cuprophan, cellulose acetate and polysul-
fone) and that this rise disappears after adjustment for BWL
argues strongly against the hypothesis of a stimulation of their
synthesis as a predominant mechanism for their elevation
during hemodialysis. This means that the enhanced synthesis or
release of f32m from circulating blood cells observed by some
authors [40, 41] is insufficient to significantly increase the serum
levels of 2m during a four-hour dialysis session. As expected,
the elimination rate of the proteins is related to the membrane
permeability (UFC). For CYST C and f32m, the influence of
UFC is characterized by a threshold value around 15 ml/hr
m2 mm Hg above which the proteins can be eliminated. These
results confirm the previous observations made with f32m [9, 10,
42].
The availability of information on four simultaneously tested
microproteins of various molecular size provides a unique
opportunity to analyze the physical determinants of protein
clearance by the membranes. When data obtained with the four
microproteins are combined, the stepwise regression demon-
strates that changes in serum protein concentration during
dialysis are determined primarily by their Mr followed by the
UFC of the membrane and the BWL. Knowing the Mr of the
various proteins and their percentage change (normalized for
BWL) during dialysis for each category of UFC, we were able
to estimate the effective pore radius of the various membranes.
As illustrated in Figure 4, the effective pore radius of high flux
membranes lies apparently between 1.5 and 1.7 nm, whereas
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Fig. 4. Influence of the ultrafiltration coefficient (UFC) and of the
effective hydrodynamic radius or molecular radius (Mr) on the removal
of low molecular weight plasma proteins during hemodialysis. Symbols
are: (U) UFC <15; (0) 15—20; (Lx) >20 ml/hr m2 mm Hg. Values
have been adjusted for body weight loss on the basis of the partial
regression coefficient.
hemodialyzed patients. The deposition in bone joints certainly
plays a role for proteins that have a fibrillar configuration (J32m
and perhaps CYST C) [34—36], although the exact contribution
of these deposits is difficult to quantify. With respect to RBP the
liver appears as a probable site of catabolism. Experimental
studies indicate that in normal rats liver can account for up to
30% of the catabolism of plasma RBP [43], and one can logically
postulate that this contribution increases during renal failure.
The removal of plasma RBP by the liver seems, however, to
involve specific surface cell receptors, and it is unlikely that
such receptors exist for all microproteins. The possibility of a
feedback control in the synthesis of microproteins cannot be
formally excluded, but seems improbable considering the diver-
sity of their sources. These considerations lead us to postulate
the existence of other routes for the disposal of LMWP in
hemodialysis patients, especially in anuric patients, in addition
to the amyloid deposits and liver uptake.
In conclusion, the variations of serum concentrations of low
molecular weight proteins in long-term hemodialysis patients
are determined, before dialysis, by residual diuresis, age and
sex, and during the dialysis session, by the size of the protein,
the ultrafiltration coefficient of the dialysis membrane and the
body weight loss. The duration of hemodialysis treatment and
the permeability of the membranes did not influence the pre-
dialysis serum levels of microproteins.
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